Daptomycin or vancomycin for methicillin-resistant staphylococcus aureus with a vancomycin minimum inhibitory concentration >1 μg/L

Clinical Infectious Diseases

Volumn 54, Issue 9, 2012, Pages 1375-1376

  López Cortés, Luis E ^a   Pascual, Álvaro ^a,b,c   Rodríguez Baño, Jesús ^a,b,d  

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Falcultad de Medicina   (Spain)

^d UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; BLOODSTREAM INFECTION; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; PATIENT DECISION MAKING; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; DAPTOMYCIN; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS; VANCOMYCIN;

EID: 84859734752     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis123     Document Type: Letter

References (1)

1. Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomcyin minimum inhibitory concentration: a casecontrol study. Clin Infect Dis 2012; 54:51-8.